<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36187464</PMID><DateRevised><Year>2022</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2220-6124</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>25</Day></PubDate></JournalIssue><Title>World journal of nephrology</Title><ISOAbbreviation>World J Nephrol</ISOAbbreviation></Journal><ArticleTitle>Management and outcomes of acute post-streptococcal glomerulonephritis in children.</ArticleTitle><Pagination><StartPage>139</StartPage><EndPage>145</EndPage><MedlinePgn>139-145</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5527/wjn.v11.i5.139</ELocationID><Abstract><AbstractText>Acute post-streptococcal glomerulonephritis (APSGN) is the major cause of acute glomerulonephritis among children, especially in low- and middle-income countries. APSGN commonly occurs following pharyngitis due to the activation of antibodies and complements proteins against streptococcal antigens through the immune-complex-mediated mechanism. APSGN can be presented as acute nephritic syndrome, nephrotic syndrome, and rapidly progressive glomerulonephritis, or it may be subclinical. The management of APSGN is mainly supportive in nature with fluid restriction, anti-hypertensives, diuretics, and renal replacement therapy with dialysis, when necessary, as the disease is self-limiting. Congestive heart failure, pulmonary edema, and severe hypertension-induced encephalopathy might occur during the acute phase of APSGN due to hypervolemia. APSGN generally has a favorable prognosis with only a small percentage of patients with persistent urinary abnormalities, persistent hypertension, and chronic kidney disease after the acute episode of APSGN. Decreased complement levels, increased C-reactive protein, and hypoalbuminemia are associated with disease severity. Crescent formations on renal biopsy and renal insufficiency on presentation may be the predictors of disease severity and poor outcomes in APSGN in children.</AbstractText><CopyrightInformation>&#xa9;The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ong</LastName><ForeName>Leong Tung</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia. leotungong@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Nephrol</MedlineTA><NlmUniqueID>101610229</NlmUniqueID><ISSNLinking>2220-6124</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Nephritic syndrome</Keyword><Keyword MajorTopicYN="N">Nephrotic-range proteinuria</Keyword><Keyword MajorTopicYN="N">Pediatrics</Keyword><Keyword MajorTopicYN="N">Post-streptococcal glomerulonephritis</Keyword></KeywordList><CoiStatement>Conflict-of-interest statement: The author reports no relevant conflict of interest for this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>3</Day><Hour>4</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36187464</ArticleId><ArticleId IdType="pmc">PMC9521512</ArticleId><ArticleId IdType="doi">10.5527/wjn.v11.i5.139</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Demircioglu K&#x131;l&#x131;c B, Akbal&#x131;k Kara M, Buyukcelik M, Balat A. Pediatric post-streptococcal glomerulonephritis: Clinical and laboratory data. Pediatr Int. 2018;60:645&#x2013;650.</Citation><ArticleIdList><ArticleId IdType="pubmed">29729114</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagan R, Cleper R, Davidovits M, Sinai-Trieman L, Krause I. Post-Infectious Glomerulonephritis in Pediatric Patients over Two Decades: Severity-Associated Features. Isr Med Assoc J. 2016;18:336&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">27468526</ArticleId></ArticleIdList></Reference><Reference><Citation>Kari JA, Bamagai A, Jalalah SM. Severe acute post-streptococcal glomerulonephritis in an infant. Saudi J Kidney Dis Transpl. 2013;24:546&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pubmed">23640628</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong W, Morris MC, Zwi J. Outcome of severe acute post-streptococcal glomerulonephritis in New Zealand children. Pediatr Nephrol. 2009;24:1021&#x2013;1026.</Citation><ArticleIdList><ArticleId IdType="pubmed">19096879</ArticleId></ArticleIdList></Reference><Reference><Citation>Han KH, Lee KH, Park SJ, Yu R, Kim SH, Lee IR, Han SY, Kim HS, Kronbichler A, Li H, Koyanagi A, Jacob L, Shin JI, Kim JH, Smith L. Hypocomplementemia (C3) as an independent predictor for children with acute post-streptococcal glomerulonephritis: a long-term observation. Eur Rev Med Pharmacol Sci. 2021;25:5674&#x2013;5683.</Citation><ArticleIdList><ArticleId IdType="pubmed">34604959</ArticleId></ArticleIdList></Reference><Reference><Citation>Steer AC, Danchin MH, Carapetis JR. Group A streptococcal infections in children. J Paediatr Child Health. 2007;43:203&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">17444820</ArticleId></ArticleIdList></Reference><Reference><Citation>Balasubramanian R, Marks SD. Post-infectious glomerulonephritis. Paediatr Int Child Health. 2017;37:240&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">28891413</ArticleId></ArticleIdList></Reference><Reference><Citation>VanDeVoorde RG 3rd. Acute poststreptococcal glomerulonephritis: the most common acute glomerulonephritis. Pediatr Rev. 2015;36:3&#x2013;12; quiz 13.</Citation><ArticleIdList><ArticleId IdType="pubmed">25554106</ArticleId></ArticleIdList></Reference><Reference><Citation>Eison TM, Ault BH, Jones DP, Chesney RW, Wyatt RJ. Post-streptococcal acute glomerulonephritis in children: clinical features and pathogenesis. Pediatr Nephrol. 2011;26:165&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652330</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Iturbe B, Najafian B, Silva A, Alpers C. Acute postinfectious glomerulonephritis in children. In: Avner E, Harmon W, Niaudet P, Yoshikawa N, editors. Pediatric Nephrology. 7th ed. New York: Lippincott Williams and Wilkins; 2016: p959&#x2013;969.</Citation></Reference><Reference><Citation>Kilic H, Karalezli A, Hasanoglu HC, Erel O, Ates C. The relationship between hs-CRP and asthma control test in asthmatic patients. Allergol Immunopathol (Madr) 2012;40:362&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pubmed">22284830</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt EAK, Somers MJG. Infection-Related Glomerulonephritis. Pediatr Clin North Am. 2019;66:59&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">30454751</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam D, Scholz H, Helmerking M. Comparison of short-course (5 day) cefuroxime axetil with a standard 10 day oral penicillin V regimen in the treatment of tonsillopharyngitis. J Antimicrob Chemother. 2000;45 Suppl:23&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">10759359</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholz H. Streptococcal-A tonsillopharyngitis: a 5-day course of cefuroxime axetil vs a 10-day course of penicillin V. results depending on the children's age. Chemotherapy 2004; 50: 51-54 .</Citation><ArticleIdList><ArticleId IdType="pubmed">15084807</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinks A, Glasziou PP, Del Mar CB. Antibiotics for sore throat. Cochrane Database Syst Rev 2013: CD000023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6457983</ArticleId><ArticleId IdType="pubmed">24190439</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Nofal A, Lteif A. Thiazide Diuretics in the Management of Young Children with Central Diabetes Insipidus. J Pediatr. 2015;167:658&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pubmed">26130110</ArticleId></ArticleIdList></Reference><Reference><Citation>Nourse PJ, McCulloch MI. Evaluation of the safety of short-acting nifedipine use in children with severe hypertension secondary to acute post-streptococcal glomerulonephritis. South African J Child Health. 2007;1</Citation></Reference><Reference><Citation>Yiu V, Orrbine E, Rosychuk RJ, MacLaine P, Goodyer P, Girardin C, Gowrishankar M, Ogborn M, Midgley J, Filler G, Harley F. The safety and use of short-acting nifedipine in hospitalized hypertensive children. Pediatr Nephrol. 2004;19:644&#x2013;650.</Citation><ArticleIdList><ArticleId IdType="pubmed">15054645</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger DW, Deming DD, Hamada N, Perkin RM, Sahney S. Evaluation of the safety of short-acting nifedipine in children with hypertension. Pediatr Nephrol. 2002;17:35&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">11793132</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobkova I, Chebotareva N, Kozlovskaya L, Shilov E. Edema in Renal Diseases &#x2013; Current View on Pathogenesis. Nephrology @ Point of Care. 2016:pocj.5000204.</Citation></Reference><Reference><Citation>Langer T, D'Oria V, Spolidoro GCI, Chidini G, Scalia Catenacci S, Marchesi T, Guerrini M, Cislaghi A, Agostoni C, Pesenti A, Calderini E. Fluid therapy in mechanically ventilated critically ill children: the sodium, chloride and water burden of fluid creep. BMC Pediatr. 2020;20:424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7487923</ArticleId><ArticleId IdType="pubmed">32891127</ArticleId></ArticleIdList></Reference><Reference><Citation>Simma L, Neuhaus TJ. Common diagnosis at an unusual age - pulmonary oedema in a toddler. BMJ Case Reports. 2018:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6202980</ArticleId><ArticleId IdType="pubmed">30344144</ArticleId></ArticleIdList></Reference><Reference><Citation>Hon KL, Leung KKY, Oberender F, Leung AK. Paediatrics: how to manage acute respiratory distress syndrome. Drugs Context. 2021;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8177958</ArticleId><ArticleId IdType="pubmed">34122589</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheifetz IM. Pediatric ARDS. Respir Care. 2017;62:718&#x2013;731.</Citation><ArticleIdList><ArticleId IdType="pubmed">28546374</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis SR, Pritchard MW, Thomas CM, Smith AF. Pharmacological agents for adults with acute respiratory distress syndrome. Cochrane Database Syst Rev. 2019;7:CD004477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6646953</ArticleId><ArticleId IdType="pubmed">31334568</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatric Acute Lung Injury Consensus Conference Group.. Pediatric acute respiratory distress syndrome: consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med 2015; 16: 428-439 .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5253180</ArticleId><ArticleId IdType="pubmed">25647235</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong W, Lennon DR, Crone S, Neutze JM, Reed PW. Prospective population-based study on the burden of disease from post-streptococcal glomerulonephritis of hospitalised children in New Zealand: epidemiology, clinical features and complications. J Paediatr Child Health. 2013;49:850&#x2013;855.</Citation><ArticleIdList><ArticleId IdType="pubmed">23782011</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100:S1&#x2013;S276.</Citation><ArticleIdList><ArticleId IdType="pubmed">34556256</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho MH, Kang HG. Acute kidney injury and continuous renal replacement therapy in children; what pediatricians need to know. Korean J Pediatr. 2018;61:339&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6258966</ArticleId><ArticleId IdType="pubmed">30360040</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanderson KR, Harshman LA. Renal replacement therapies for infants and children in the ICU. Curr Opin Pediatr. 2020;32:360&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7310588</ArticleId><ArticleId IdType="pubmed">32332327</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutherland SM, Zappitelli M, Alexander SR, Chua AN, Brophy PD, Bunchman TE, Hackbarth R, Somers MJ, Baum M, Symons JM, Flores FX, Benfield M, Askenazi D, Chand D, Fortenberry JD, Mahan JD, McBryde K, Blowey D, Goldstein SL. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis. 2010;55:316&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">20042260</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu RK, Wheeler DS, Goldstein S, Doughty L. Acute renal replacement therapy in pediatrics. Int J Nephrol. 2011;2011:785392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3119041</ArticleId><ArticleId IdType="pubmed">21716713</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunasekaran K, Krishnamurthy S, Mahadevan S, Harish BN, Kumar AP. Clinical Characteristics and Outcome of Post-Infectious Glomerulonephritis in Children in Southern India: A Prospective Study. Indian J Pediatr. 2015;82:896&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pubmed">25893528</ArticleId></ArticleIdList></Reference><Reference><Citation>Becquet O, Pasche J, Gatti H, Chenel C, Ab&#xe9;ly M, Morville P, Pietrement C. Acute post-streptococcal glomerulonephritis in children of French Polynesia: a 3-year retrospective study. Pediatr Nephrol. 2010;25:275&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">19876655</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasahara T, Hayakawa H, Okubo S, Okugawa T, Kabuki N, Tomizawa S, Uchiyama M. Prognosis of acute poststreptococcal glomerulonephritis (APSGN) is excellent in children, when adequately diagnosed. Pediatr Int. 2001;43:364&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pubmed">11472580</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsell DG, Wyatt RJ, Gaber LW. Terminal complement complexes in acute poststreptococcal glomerulonephritis. Pediatr Nephrol. 1994;8:671&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">7696103</ArticleId></ArticleIdList></Reference><Reference><Citation>White AV, Hoy WE, McCredie DA. Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life. Med J Aust. 2001;174:492&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pubmed">11419767</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepahi MA, Shajari A, Shakiba M, Shooshtary FK, Salimi MH. Acute glomerulonephritis: a 7 years follow up of children in center of Iran. Acta Med Iran. 2011;49:375&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pubmed">21874641</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto SWL, Mastroianni-Kirsztajn G, Sesso R. Ten-Year Follow-up of Patients with Epidemic Post Infectious Glomerulonephritis. PLoS One. 2015: e0125313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4427285</ArticleId><ArticleId IdType="pubmed">25962068</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Iturbe B, Musser JM. The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol. 2008;19:1855&#x2013;1864.</Citation><ArticleIdList><ArticleId IdType="pubmed">18667731</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivante A, Twig G, Tirosh A, Skorecki K, Calderon-Margalit R. Childhood history of resolved glomerular disease and risk of hypertension during adulthood. JAMA. 2014;311:1155&#x2013;1157.</Citation><ArticleIdList><ArticleId IdType="pubmed">24643607</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoy WE, White AV, Dowling A, Sharma SK, Bloomfield H, Tipiloura BT, Swanson CE, Mathews JD, McCredie DA. Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life. Kidney Int. 2012;81:1026&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">22297679</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>